Merck gets EU panel nod for first ever Ebola vaccine

A panel of the European drugs regulator on Friday recommended approving Merck & Co's vaccine for the deadly Ebola virus.

The European Medicines Agency said its human medicines committee (CHMP) has recommended granting a conditional marketing authorization in the European Union for the vaccine, Ervebo, for individuals aged 18 years and older.

Also Read: U.S. House panel wants Facebook's Zuckerberg to testify on Libra by January